Iron chelation therapy could reduce oxidative DNA damage in hematopoietic cells in patients with myelodysplastic syndrome.

Masayoshi Kobune

10:00 AM - 10:30 AM

[3S02-3] Iron chelation therapy could reduce oxidative DNA damage in hematopoietic cells in patients with myelodysplastic syndrome.

^○Masayoshi Kobune¹, Shohei Kikuchi², Hiroto Horiguchi¹, Kazuyuki Murase^1,2, Satoshi Iyama¹, Tsutomu Sato¹, Koichi Takada^1,2, Shogo Miura^1,2, Soushi Ibata^1,2, Masahiro Yoshida^1,2, Koji Miyanishi², Junji Kato² (1.Department of Hematology, 2.Department of Medical Oncology)

鉄キレート療法, 酸化的ＤＮＡ損傷, 骨髄異形成症候群

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 89th Annual Meeting of JBS

[3S02-3] Iron chelation therapy could reduce oxidative DNA damage in hematopoietic cells in patients with myelodysplastic syndrome.

Password